TMCnet News

Research and Markets: Global Autism Therapeutics Pipeline Review 2015 - 23 Companies & 35 Drug Profiles
[February 26, 2015]

Research and Markets: Global Autism Therapeutics Pipeline Review 2015 - 23 Companies & 35 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/5scwl9/autism_pipeline) has announced the addition of the "Autism - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Autism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Autism and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • Addex Therapeutics Ltd
  • Avanir Pharmaceuticals, Inc.
  • BiCrea GmbH
  • BrainStorm Cell Therapeutics Inc.
  • Cellceutix Corporation
  • Confluence Pharmaceuticals LLC
  • Curemark, LLC
  • Edison Pharmaceuticals, Inc.
  • Egenix, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Heptares Therapeutics Ltd.
  • Intra-Cellular Therapies, Inc.
  • MedDay
  • Merz Pharma GmbH & Co. KgaA
  • Mitsubishi (News - Alert) Tanabe Pharma Corporation
  • Mnemosyne Pharmaceuticals, Inc.
  • Novartis AG
  • Omeros Corporation
  • Otsuka Holdings Co., Ltd.
  • Reviva Pharmaceuticals Inc.
  • Saniona AB
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Teva Pharmaceutical Industries Limited



Drug Profiles

  • (dextromethorphan hydrobromide + quinidine sulfate)
  • acamprosate calcium
  • ADX-88178
  • aripiprazole
  • carbetocin
  • CM-AT
  • CN-2097
  • CNDO-201
  • Drug for Autism
  • Drug for Autism Spectrum (News - Alert) Disorders
  • Fingolimod hydrochloride
  • Fluoxetine
  • Glatiramer acetate
  • HTL-14242
  • ITI-007
  • KM-391
  • lurasidone hydrochloride
  • MD-1103
  • Small Molecule to Agonize GABAA Receptor Subunit Alpha-5 for Autism
  • Small Molecule to Antagonize NMDA2A for Central Nervous System Disorder
  • Small Molecule to Modulate GABRA5 Receptor for Alzheimer's Disease, Schizophrenia and Autism
  • Small Molecule to Target (News - Alert) GPR63 for Autism
  • Small Molecules to Agonize GABAA-Beta 2 Receptor for Epilepsy and Autism
  • Small Molecules to Inhibit PI3K for Autism and Fragile X Syndrome
  • Small Molecules to Inhibit Translation Initiation Factor-4E for Cancer and Autism
  • Small Molecules to Target Oxytocin for Autism and Anxiety Disorders
  • Stem Cell Therapy for Autism
  • Stem Cell Therapy for Neurodegenerative Disorders
  • Suramin hexasodium
  • Vatiquinone

For more information visit http://www.researchandmarkets.com/research/5scwl9/autism_pipeline



[ Back To TMCnet.com's Homepage ]